siRNA Design Guidelines
Using siRNA for gene silencing is a
rapidly evolving tool in molecular biology. There are several methods
for preparing siRNA, such as chemical synthesis, in vitro transcription,
siRNA expression vectors, and PCR expression cassettes. Irrespective
of which method one uses, the first step in designing a siRNA is
to choose the siRNA target site. The guidelines below for choosing
siRNA target sites are based on both the current literature, and
on empirical observations by scientists at Ambion. Using these
guidelines, approximately half of all siRNAs yield >50% reduction
in target mRNA levels.
General Design Guidelines
If you prefer to design your own siRNAs, you can choose siRNA target
sites in a variety of different organisms based on the following
guidelines. Corresponding siRNAs can then be chemically synthesized,
created by in vitro transcription, or expressed from a vector or
PCR product.
1. Find 21 nt sequences in the target mRNA that begin with an AA
dinucleotide.
Beginning with the AUG start codon of your transcript, scan for
AA dinucleotide sequences. Record each AA and the 3' adjacent 19
nucleotides as potential siRNA target sites.
This strategy for choosing siRNA target sites is based on the
observation by Elbashir et al. (1) that siRNAs with 3' overhanging
UU dinucleotides are the most effective. This is also compatible
with using RNA pol III to transcribe hairpin siRNAs because RNA
pol III terminates transcription at 4-6 nucleotide
poly(T) tracts creating RNA molecules with a short poly(U) tail.
In Elbashir's and subsequent publications, siRNAs with other 3' terminal dinucleotide
overhangs have been shown to effectively induce RNAi. If desired, you may modify
this target site selection strategy to design siRNAs with other dinucleotide
overhangs, but it is recommended that you avoid G residues in the overhang
because of the potential for the siRNA to be cleaved by RNase at single-stranded
G residues.
2. Select 2-4 target sequences.
Research at Ambion has found that typically more than half of
randomly designed siRNAs provide at least a 50% reduction in target
mRNA levels and approximately 1 of 4 siRNAs provide a 75-95% reduction.
Choose target sites from among the sequences identified in Step
1 based on the following guidelines:
- Ambion researchers find that siRNAs with 30-50% GC
content are more active than those with a higher G/C content.
- Since a 4-6 nucleotide poly(T) tract acts as a termination
signal for RNA pol III, avoid stretches of > 4 T's or A's
in the target sequence when designing sequences to be expressed
from an RNA pol III promoter.
- Since some regions of mRNA may be either highly structured
or bound by regulatory proteins, we generally select siRNA target
sites at different positions along the length of the gene sequence.
We have not seen any correlation between the position of target
sites on the mRNA and siRNA potency.
- Compare the potential target sites to the appropriate
genome database (human, mouse, rat, etc.) and eliminate from
consideration any target sequences with more than 16-17 contiguous base pairs
of homology to other coding sequences. We suggest using BLAST,
which can be found on the NCBI server at:
www.ncbi.nlm.nih.gov/BLAST.
3. Design appropriate controls.
A complete siRNA experiment should include a number of controls
to ensure the validity of the data. The editors of Nature
Cell Biology have recommended several controls (2). Two
of these controls are:
- A negative control siRNA with the same nucleotide
composition as your siRNA but which lacks significant sequence
homology to the genome. To design a negative control siRNA,
scramble the nucleotide sequence of the gene-specific siRNA and
conduct a search to make sure it lacks homology to any other gene.
- Additional siRNA sequences targeting the same mRNA.
Perhaps the best way to ensure confidence in RNAi data is to perform
experiments, using a single siRNA at a time, with two or more different
siRNAs targeting the same gene. Prior to these experiments, each
siRNA should be tested to ensure that it reduces target gene expression
by comparable levels.
Ambion's siRNA Target Finder
Use our online
target finder to find potential sequences based on the
design guidelines described above. Simply paste your mRNA sequence
into the window and this program will scan your sequence for
AA dinucleotides. A report is generated indicating the position
of the AA dinucleotide, the 21 base target and the corresponding
sense and antisense siRNA oligonucleotides. siRNA targets can
then be sent directly to one of our kit-specific design tools
or subjected to a BLAST search by clicking on the appropriate
link below the target of interest.
Alternatively, the Whitehead Institute of Biomedical Research at
MIT has a publicly available siRNA design tool that incorporates
additional selection parameters and integrates BLAST searches of
the human and mouse genome databases. See http://jura.wi.mit.edu/bioc/siRNAext/ (registration
required).
Specific Guidelines for Designing siRNA Hairpins Encoded by siRNA
Expression Vectors and siRNA Expression Cassettes
Researchers who initially reported the use of siRNA expression
vectors to induce RNAi had different design criteria for their inserts
encoding the expressed siRNA. Most of the designs had two inverted
repeats separated by a short spacer sequence and ended with a string
of T's that served as a transcription termination site. These designs
produce an RNA transcript that is predicted to fold into a short
hairpin siRNA as shown in Figure 1. The selection of siRNA target
sequence, the length of the inverted repeats that encode the stem
of a putative hairpin, the order of the inverted repeats, the length
and composition of the spacer sequence that encodes the loop of the
hairpin, and the presence or absence of 5'-overhangs, vary among
different reports (3-11).

|
Figure 1 . Schematic
of a Typical Hairpin siRNA Produced by an siRNA Expression
Vector or an siRNA Expression Cassette and Its Relationship
to the RNA Target Sequence. |
Ambion's Recommended Procedure for siRNA Hairpin Design
The following recommendations for siRNA hairpin design and cloning
strategy are made based on research by Ambion scientists. The first
step in designing an appropriate insert is to choose the siRNA target
site by following the steps described under "General Design
Guidelines" above.
For screening, we typically test four siRNA sequences per target,
spacing the siRNA sequences down the length of the gene sequence
to reduce the chances of targeting a region of the mRNA
that is either highly structured or bound by regulatory proteins.
Because constructing and testing four siRNA expression plasmids per
target is time-consuming, we find it much easier to screen potential
siRNA sequences using PCR-derived siRNA expression cassettes (SECs).
SECs are PCR products that include promoter and terminator sequences
flanking a hairpin siRNA template. This screening strategy also permits the rapid identification
of the best combination of promoter and siRNA sequence in the experimental
system. SECs found to effectively elicit gene silencing can be readily
cloned into a vector for long term studies. Ambion scientists have
determined that sequences that function well as transfected siRNAs
also function well as siRNAs that are expressed in vivo. The only
exception is that siRNA sequences to be expressed in vivo should
not contain a run of 4 or 5 A's or T's, as these can act as termination
sites for Polymerase III.
For traditional cloning into pSilencer vectors, two DNA
oligonucleotides that encode the chosen siRNA sequence are designed
for insertion into the vector (Figures 2 and 3). In general, the
DNA oligonucleotides consist of a 19-nucleotide sense siRNA sequence
linked to its reverse complementary antisense siRNA sequence by a
short spacer. Ambion scientists have successfully used a 9-nucleotide
spacer (TTCAAGAGA), although other spacers can be designed. 5-6 T's
are added to the 3' end of the oligonucleotide. In addition, for
cloning into the pSilencer 1.0-U6 vector, nucleotide overhangs
to the EcoR I and Apa I restriction sites are added
to the 5' and 3' end of the DNA oligonucleotides, respectively (Figure
2). In contrast, for cloning into the pSilencer 2.0-U6,
2.1-U6, 3.0-H1, or 3.1-H1 vectors, nucleotide overhangs with BamH
I and Hind III restriction sites are added to the 5' and
3' end of the DNA oligonucleotides, respectively (Figure 3). The
resulting RNA transcript is expected to fold back and form a stem-loop
structure comprising a 19 bp stem and 9 nt loop with 2-3 U's at the
3' end (Figure 1).

|
Figure 2. Insert
Design for pSilencer 1.0-U6.
This insert is specific for the pSilencer 1.0-U6 Vector
and contains the appropriate 3' overhangs for directional cloning
into this vector. The loop sequence and length can be varied
as desired. |

|
Figure 3 . Insert
Design for pSilencer 2.0-U6
and pSilencer 3.0-H1. The insert design is specific
for the pSilencer 2.0-U6, 2.1-U6, 3.0-H1 and 3.1-H1
Expression Vectors and contains the appropriate overhanging
5' ends for directional cloning into these plasmids. As with
pSilencer 1.0-U6 shown in Figure 2, early indications
suggest that a great deal of latitude is possible in the design
of the loop; here we provide one loop sequence that we find
works well. |
For cloning into the pSilencer adeno 1.0-CMV vector, DNA
oligonucleotides with stem-loop structures are created similar to
those of pSilencer 2.0
and 3.0 vectors described above. However, one notable
exception is the absence of 5-6 T's from the 3'-end of the oligonucleotides
for the CMV-based vector system since the transcription
termination signal for the CMV-based vector system is provided by
the SV40 polyA terminator. In addition, for cloning into the pSilencer adeno
1.0-CMV vector, nucleotide overhangs containing the Xho I
and Spe I
restriction sites are added to the 5' and 3' end of the DNA oligonucleotides,
respectively (Figure 4).
However, for cloning into the pSilencer 4.1-CMV vector,
nucleotide overhangs containing the Bam H1 and Hind III
restriction sites are added to the 5' and 3' end of the DNA oligonucleotides,
respectively (Figure 5).
|

|
|
Figure 4. Insert
Design for pSilencer™ adeno 1.0-CMV Vector. This
insert design is specific for the pSilencer adeno
1.0-CMV vector and contains the appropriate overhangs for
directional cloning into this vector. The loop sequence
and length can be varied as desired.
|
|

|
|
Figure 5. Insert
Design for pSilencer™ 4.1-CMV Vector. This
insert design is specific for the pSilencer 4.1-CMV
vector and contains the appropriate overhangs for directional
cloning into this vector. The loop sequence and length can
be varied as desired.
|
Selection of siRNA Targets
In addition to the our own proprietary algorithm and our suggested
procedure for selecting siRNA targets by scanning a mRNA sequence
for AA dinucleotides and recording the 19 nucleotides immediately
downstream of the AA, two other methods have been employed by other
researchers. In the first method, the selection of the siRNA target
sequence is purely empirically determined (4), as long as the target
sequence starts with GG and does not share significant sequence homology
with other genes as analyzed by BLAST search.
In the second report, a more elaborate method is employed to select
the siRNA target sequences. This procedure exploits an observation
that any accessible site in endogenous mRNA can be targeted for degradation
by the synthetic oligodeoxyribonucleotide/RNase H method (5). Any
accessible site identified in this fashion is then used as insert
sequence in the U6 promoter-driven siRNA constructs.
Order of the Sense and Antisense Strands within the Hairpin siRNAs
A hairpin siRNA expression cassette is usually constructed to contain
the sense strand of the target, followed by a short spacer, then
the antisense strand of the target, in that order. One group of researchers
has found that reversal of the order of sense and antisense strands
within the siRNA expression constructs did not affect the gene silencing
activities of the hairpin siRNA (6). In contrast, another group of
researchers has found that similar reversal of order in another siRNA
expression cassette caused partial reduction in the gene silencing
activities of the hairpin siRNA (7). It is not clear what is responsible
for this difference in observation. At the present time, it is still
advisable to construct the siRNA expression cassette in the order
of sense strand, short spacer, and antisense strand.
Length of the siRNA Stem
There appears to be some degree of variation in the length of nucleotide
sequence being used as the stem of siRNA expression cassette. Several
research groups including Ambion have used 19 nucleotides-long sequences
as the stem of siRNA expression cassette (6-10). In contrast, other
research groups have used siRNA stems ranging from 21 nucleotides-long
(4-5) to 25-29 nucleotides-long (11). It is found that hairpin siRNAs
with these various stem lengths all function well in gene silencing
studies.
Length and Sequence of the Loop Linking Sense and Antisense Strands
of Hairpin siRNA
Various research groups have reported successful gene silencing
results using hairpin siRNAs with loop size ranging between 3 to
23 nucleotides (4, 6-9, 11). The following is a summary of loop size
and specific loop sequences used by various research groups:
Loop Size (# of Nucleotides) |
Specific Loop Sequence |
Reference |
3 |
AUG |
4 |
3 |
CCC |
7 |
4 |
UUCG |
5 |
5 |
CCACC |
7 |
6 |
CTCGAG |
2 |
6 |
AAGCUU |
2 |
7 |
CCACACC |
7 |
9 |
UUCAAGAGA |
6 |
23 |
Not reported |
9 |
Presence of 5' Overhangs in the Hairpin siRNAs
Most research groups did not use a 5' overhang in their hairpin
siRNA construct (4-8, 10-11). However, one research group included
a 6 nucleotide 5' overhang in the hairpin siRNA constructs (9). These
hairpin siRNAs with 5' overhangs were shown to be functional in gene
silencing.
Chemical Synthesis of siRNA
Ambion synthesizes both customer designed siRNAs and siRNAs pre-designed
using the Cenix algorithm.
To order
a chemically synthesized siRNA for which you already
have the design, you can either provide:
· the ~21 base mRNA sequence (starting with the AA dinucleotide) to which
the siRNA will be directed
OR
· the sequence of each siRNA strand (This option is recommended
if you wish your siRNA to have 3' termini other than dTdT or UU.)
Ambion will synthesize a complementary pair of siRNA oligonucleotides
according to your sequence. By default, siRNAs for which you provide
only the mRNA target sequence will be synthesized with dTdT 3' overhangs.
If you wish, you can choose UU or other overhangs. Our scientists
observe no functional difference in the potency of siRNA made with
dTdT or UU overhangs. (Note: the 3' dTdT of the sense strand does
not have to be complementary to the target gene.)
Currently, Ambion Pre-designed
siRNAs are available for >98% of
all human, mouse, and rat genes in the RefSeq database maintained
by NCBI. To order a pre-designed
siRNA,
search our siRNA database for
your gene of interest, choose the design(s) you'd like to purchase,
add them to your cart, and transfer the relevant information about
each to our online oligo order form. See Designing
a Better siRNA for information on the design algorithm used.
Other Methods of siRNA Preparation
To prepare siRNA by in vitro transcription, siRNA expression vector,
or PCR-generated siRNA expression cassette, appropriate templates
must be prepared. Web-based tools for designing these templates are
available for the following Ambion kits/products:
These tools are also accessible from the siRNA Target Finder described
above.
References
1. Elbashir, et al. (2001) Functional anatomy of siRNA for mediating
efficient RNAi in Drosophila melanogaster embryo lysate. EMBO
J 20: 6877-6888.
2. Editors of Nature Cell Biology (2003) Whither RNAi? Nat Cell
Biol. 5:489-490.
3. Brown, D., Jarvis, R., Pallotta, V., Byrom, M., and Ford, L.
(2002) RNA interference in mammalian cell culture: design, execution,
and analysis of the siRNA effect. Ambion TechNotes 9(1):
3-5.
4. Sui, G., Soohoo, C., Affar, E.B., Gay, F., Shi, Y., Forrester,
W.C., and Shi, Y. (2002) A DNA vector-based RNAi technology to suppress
gene expression in mammalian cells. Proc. Natl. Acad. Sci. US A
99(8): 5515-5520.
5. Lee, N.S., Dohjima, T., Bauer, G., Li, H., Li, M.-J., Ehsani,
A., Salvaterra, P., and Rossi, J. (2002) Expression of small interfering
RNAs targeted against HIV-1 rev transcripts in human cells. Nature
Biotechnology 20 : 500-505.
6. Yu, J.-Y., DeRuiter, S.L., and Turner, D.L. (2002) RNA interference
by expression of short-interfering RNAs and hairpin RNAs in mammalian
cells. Proc. Natl. Acad. Sci. USA 99(9) : 6047-6052.
7. Paul, C.P., Good, P.D., Winer, I., and Engelke, D.R. (2002) Effective
expression of small interfering RNA in human cells. Nature Biotechnology 20 :
505-508.
8. Brummelkamp, T.R., Bernards, R., and Agami, R. (2002) A system
for stable expression of short interfering RNAs in mammalian cells. Science 296 :
550-553.
9. Jacque, J.-M., Triques, K., and Stevenson, M. (2002) Modulation
of HIV-1 replication by RNA interference. Nature 418 :
435-438.
10. Miyagishi, M., and Taira, K. (2002) U6 promoter-driven siRNAs
with four uridine 3' overhangs effectively suppress targeted gene
expression in mammalian cells. Nature Biotechnology 20 :
497-500.
11. Paddison, P.J., Caudy, A.A., Berstein,
E., Hannon, G.J., and Conklin, D.S. (2002) Short hairpin RNAs (shRNAs)
induce sequence-specific silencing in mammalian cells. Genes Devel.
16: 948-958.
Related Articles
|